苯妥英生物利用度的非线性评估。 - Suppr

Suppr

超能文献

Nonlinear assessment of phenytoin bioavailability.

作者信息

Jusko W J, Koup J R, Alván G

出版信息

J Pharmacokinet Biopharm. 1976 Aug;4(4):327-36. doi: 10.1007/BF01063122.

DOI:10.1007/BF01063122

PMID:978395

Abstract

摘要

相似文献

Nonlinear assessment of phenytoin bioavailability.

J Pharmacokinet Biopharm. 1976 Aug;4(4):327-36. doi: 10.1007/BF01063122.

Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.

Clin Pharmacokinet. 1979 Mar-Apr;4(2):91-103. doi: 10.2165/00003088-197904020-00002.

The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.

Br J Clin Pharmacol. 1982 Apr;13(4):501-5. doi: 10.1111/j.1365-2125.1982.tb01411.x.

Effect of calcium and antacids on phenytoin bioavailability.

Arch Neurol. 1979 Jul;36(7):436-8. doi: 10.1001/archneur.1979.00500430066010.

Effect of formulation on dissolution and bioavailability of phenytoin tablets.

Pharmazie. 1980;35(10):627-9.

Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate.

Chem Pharm Bull (Tokyo). 1978 Oct;26(10):3033-9. doi: 10.1248/cpb.26.3033.

Dissolution behavior and bioavailability of phenytoin from a ground mixture with microcrystalline cellulose.

J Pharm Sci. 1976 Oct;65(10):1484-8. doi: 10.1002/jps.2600651017.

Oral phenytoin in infancy: dose requirement, absorption, and elimination.

Pediatr Pharmacol (New York). 1983;3(3-4):229-36.

The effects of sucralfate upon phenytoin absorption in man.

Br J Clin Pharmacol. 1985 Sep;20(3):238-40. doi: 10.1111/j.1365-2125.1985.tb05067.x.

In vitro and in vivo availability of hydrophilized phenytoin from capsules.

J Pharm Sci. 1979 May;68(5):634-8. doi: 10.1002/jps.2600680533.

引用本文的文献

Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets.

Front Vet Sci. 2022 Dec 7;9:1054417. doi: 10.3389/fvets.2022.1054417. eCollection 2022.

Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.

Eur J Drug Metab Pharmacokinet. 2016 Oct;41(5):527-39. doi: 10.1007/s13318-015-0292-3.

Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.

Eur J Drug Metab Pharmacokinet. 2013 Jun;38(2):139-48. doi: 10.1007/s13318-012-0105-x. Epub 2012 Sep 12.

Bioequivalence tests based on individual estimates using non-compartmental or model-based analyses: evaluation of estimates of sample means and type I error for different designs.

Pharm Res. 2010 Jan;27(1):92-104. doi: 10.1007/s11095-009-9980-5. Epub 2009 Oct 30.

Pharmacokinetics of 1,4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability.

AAPS J. 2008;10(1):56-69. doi: 10.1208/s12248-007-9006-3. Epub 2008 Feb 8.

Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.

Biopharm Drug Dispos. 2007 Sep;28(6):263-73. doi: 10.1002/bdd.551.

Phenytoin pharmacokinetics and clinical effects in African children following fosphenytoin and chloramphenicol coadministration.

Br J Clin Pharmacol. 2002 Dec;54(6):635-42. doi: 10.1046/j.1365-2125.2002.01689.x.

Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit.

Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun;27(2):83-9. doi: 10.1007/BF03190421.

Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.

Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):295-300. doi: 10.1007/BF03189354.

Application of a simplified method to determine bioavailability of an oral dose of phenytoin.

J Pharmacokinet Biopharm. 1993 Apr;21(2):195-208. doi: 10.1007/BF01059770.

本文引用的文献

Phenytoin dose adjustment in epileptic patients.

Br J Clin Pharmacol. 1974 Apr;1(2):163-8. doi: 10.1111/j.1365-2125.1974.tb00226.x.

Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455-66.

Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics.

J Pharm Sci. 1972 Apr;61(4):541-4. doi: 10.1002/jps.2600610409.

Pharmacokinetics of single and multiple doses of phenytoin in man.

Eur J Clin Pharmacol. 1974;7(2):81-6. doi: 10.1007/BF00561319.

Bioavailability, clinical effectiveness, and the public interest.

Pharmacology. 1972;8(1):33-43. doi: 10.1159/000136325.

Bioavailability of diphenylhydantoin.

Clin Pharmacol Ther. 1974 Oct;16(4):727-35. doi: 10.1002/cpt1974164727.

Phenytoin: pharmacokinetics and bioavailability.

Clin Pharmacol Ther. 1976 Feb;19(2):135-42. doi: 10.1002/cpt1976192135.

Diphenylhydantoin elimination kinetics in overdosed children.

Clin Pharmacol Ther. 1975 Apr;17(4):481-91. doi: 10.1002/cpt1975174481.

Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.

Clin Pharmacol Ther. 1975 Oct;18(4):449-56. doi: 10.1002/cpt1975184449.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验